Join Aker BioMarine for an exclusive webinar diving into the rapidly expanding GLP-1 market. Featuring market and consumer insights from an expert at Nutrition Business Journal, the session will cover how consumers perceive GLP-1s, their expectations, and the opportunities this creates for brands and companion products.

Our science team will break down the findings and results of Aker BioMarine’s new clinical study, which demonstrates how krill oil can help preserve muscle mass and support healthy weight loss for individuals using GLP-1s. The discussion will highlight why maintaining lean muscle is critical during weight management, and how companion products like krill oil can provide an essential layer of support alongside GLP-1 therapies.

This session will give you the science, strategy, and market perspective you need to stay ahead in one of the most dynamic categories in nutrition today.

About the Presenters

Bill Giebler

Content & Insights Director

Nutrition Business Journal

Bill Giebler is the Content and Insights Director at Informa’s Nutrition Business Journal, where he manages the editorial and data analytics teams, drawing on his experience both as a journalist and a business manager in dietary supplements retail, natural products product development and more.

Since 1996, NBJ has offered business intelligence and thought leadership to all levels of the nutrition industry. At the core of this is the market-sizing data that shows the What, Where and Why of the dietary supplement industry. That is, the ingredients (vitamins, herbs/botanicals, sports nutrition, specialty ingredients and minerals), the channels in which they are sold (natural foods stores, vitamin shops, mass market retailers, e-commerce, MLMs and the practitioner channel), and the health conditions for which consumers are purchasing them.

Dr. Yunpeng Ding

PhD, Director R&D, Human Nutritrion

Aker BioMarine

Dr. Yunpeng Ding is a senior researcher, currently serving as R&D Director in the Innovation team at Aker Biomarine. He supervises clinical research on the health benefits of omega-3 fatty acids for the company’s human nutrition product – krill oil. Before joining Aker BioMarine in 2020, Dr. Ding served as chief biostatistician for a European CRO in pharmaceutical industry where he was responsible for designing, analyzing, and reporting multiple Phase I-III clinical trials.

He obtained his medical degree from China in 2008, MSc Public Health in 2011, and PhD in Epidemiology and Biostatistics from University of Bergen, Norway in 2016.

Cashtyn Lovan

Marketing and Business Development Director

Aker BioMarine 

Cashtyn Lovan is the Marketing Director and Business Development Director at Aker BioMarine with over 10 years of marketing experience the in the Dietary Supplement industry. With a background of working with specialized branded ingredients, she is an expert at simplifying complex, technical information making it easier to understand and more relevant to consumers.